DepYmed

0 followers


DepYmed Inc. is a New York-based cancer and rare disease therapeutic development company. DepYmed is currently developing potent inhibitors of the enzyme PTP1B (protein tyrosine phosphatase 1B) as potential novel therapeutics for HER2-positive breast cancer and Rett Syndrome.

Industries

Headquarters

Stage

Employees

Links

Org chart

Andreas G. Grill
President, CEO & Director

Andreas G. Grill

Collapse
Peter Van Ess
VP, Early Development